Tango Therapeutics Inc

NASDAQ:TNGX   3:59:51 PM EDT
13.55
-1.24 (-8.38%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.09B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$6.41 Million
Adjusted EPS-$0.27
See more estimates
10-Day MA$15.12
50-Day MA$12.12
200-Day MA$11.51
See more pivots

Tango Therapeutics Inc Stock, NASDAQ:TNGX

100 Binney Street, Unit 700, Cambridge, Massachusetts 02142
United States of America
Phone: +1.857.320.4900
Number of Employees: 4

Description

Tango Therapeutics, Inc. operates as a biotechnology company that engages in discovering and delivering precision cancer medicines. The company was founded by Alan Ashworth, William G. Kaelin, Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Cambridge, MA.